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OBJECTIVES: To review how the Hunter Outcome Survey (HOS), a physician-driven, 
multinational, observational survey supported by Shire HGT, has helped advance 
the understanding and management of Hunter syndrome—a rare, X-linked disorder
of glycosaminoglycan (GAG) metabolism caused by deﬁ ciency of the enzyme iduro-
nate-2-sulfatase. METHODS: HOS was established in 2005 to help understand the 
natural history of Hunter syndrome and the long-term safety and effectiveness of 
enzyme replacement therapy (ERT) with idursulfase. Data such as demographics,
signs/symptoms, investigations, developmental milestones and laboratory test data
are collected for patients with a conﬁ rmed diagnosis. Three working groups
(Natural History, Cardiac and CNS) have been established to further data collection/
interpretation in the respective ﬁ elds. RESULTS: As of January 2009, 98 clinics across
23 countries have enrolled 642 patients. The ﬁ rst peer-reviewed paper, published in 
2008, reported that the median ages of onset of symptoms and diagnosis were 1.5
and 3.5 years, respectively; the average height of Hunter children was normal up
to approximately 9 years of age, following which it fell below the third percentile 
(Wraith et al., 2008). Other important ﬁ ndings include: by 6 years of age half 
of patients showed cardiovascular abnormalities (Wraith et al., 2007); the majority 
of patients developed airway involvement in childhood (Burton et al., 2008); and 
prior to diagnosis, the most common clinical symptoms were characteristic facial 
features, enlarged liver and spleen, hernia and otitis (Beck et al., 2007). CONCLU-
SIONS: In the short time HOS has been running, it has provided important real-
world data on Hunter syndrome. Data analyses have identiﬁ ed the need for early 
diagnosis, to enable institution of appropriate therapeutic management. Through 
ongoing collaboration between participating physicians and working groups, HOS
will continue to expand the evidence base of knowledge around Hunter Syndrome
and be a valuable tool to evaluate the effectiveness of ERT and help optimize patient
care.
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OBJECTIVES: Crohn’s disease (CD) causes inﬂ ammation in the lining of the small
or large intestine and is characterized by disease ﬂ ares. This study quantiﬁ ed the
incidence of disease ﬂ ares among adult patients with CD, and assessed the impact 
of ﬂ ares on resource utilization. METHODS: Cross-sectional data were collected via 
the Inﬂ ammatory Bowel Disease (IBD) Study Project during Q3 2008. Study partici-
pants were recruited from an Internet panel and were reported to have IBD as diag-
nosed by a physician. All survey respondents were aged q18 years. RESULTS: A total
of 500 patients with CD completed the survey. Overall, 32.0% of all CD patients
reported one or more ﬂ ares per week, while an additional 26.8% reported one or
more ﬂ ares per month. Patients reporting one or more ﬂ ares per week were signiﬁ -
cantly younger (42.2 years) and had CD for shorter lengths of time (11.7 years) than 
patients with less frequent disease ﬂ ares. The former were more likely to classify their
disease as moderate to severe, uncontrolled, and more bothersome. The majority of 
disease ﬂ ares lasted less than one week and were of moderate severity. Patients expe-
riencing more frequent disease ﬂ ares were signiﬁ cantly more likely to have been hos-
pitalized (28.8% vs. 6.5%), have longer lengths of stay (2.2 days vs. 0.9 days), visited 
the emergency room (40.6% vs. 6.5%), and visited their gastroenterologist (60.6% 
vs. 32.3%) in the past six months as a result of their CD. These patients were also 
more likely to have higher degrees of work productivity loss. CONCLUSIONS: The 
majority of patients with CD experience disease ﬂ ares at least monthly, and the more
frequent the ﬂ ares, the greater the resource utilization and disruption to work life. 
Treatments that adequately control disease ﬂ ares may result in cost offsets and should
be examined.
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OBJECTIVES: To describe rates of inappropriate utilization, abuse, and diversion in
a population of patients who were prescribed chronic opioids, as measured by urine
drug testing (UDT) in the clinical setting. A secondary objective is to inform providers, 
payors and policy-makers about the importance of routine monitoring of patients on
chronic opioids. METHODS: A retrospective analysis was conducted of a database 
containing results from all urine drug tests conducted between January 2006 and 
September 2008, by Ameritox, Ltd. using their RxGuardian(sm) monitoring algo-
rithms, for patients whose physicians ordered the test in order to screen for non-
compliance. RESULTS: Data from over 800,000 patient test samples obtained from 
over 500,000 unique patients showed that 75% of patients were deemed “noncompli-
ant” with their prescribed pain regimen. Of patients determined to be noncompliant; 
39% were found to not have the prescribed opioid present, 29% had non-prescribed
opioid medications present, 27% had a drug level higher than expected, 15% had a
drug level lower than expected, and 11% had illicit drugs detected in their urine. 
CONCLUSIONS: The high observed rate of noncompliance in this patient population
implies high rates of non-adherence, overuse, and diversion of prescribed opioid 
medications. Previous research has compared direct per-patient costs of insured opioid 
abusers versus non-abusers, and found signiﬁ cantly higher health care costs for opioid
abusers. These higher costs have been attributed to increased utilization of services
and prescription products, as well as more frequent comorbidities. Utilizing a UDT
that can not only detect the presence of other non-prescribed and illicit drugs, but also
is sensitive enough to determine whether the patient is adherent to their current 
regimen provides a powerful tool for clinicians seeking to identify and decrease non-
compliance, overuse, and diversion of controlled substances in their practice.
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USING UTILIZATION RECORDS TO ESTIMATE THE BURDEN OF
OBESITY IN ADULTS LIVING IN ONTARIO
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OBJECTIVES: To present an overview of the burden of obesity in adults by using the 
richness of a Canadian population health survey linked to Ontario administrative 
databases. METHODS: The records of all Ontarians who participated in the Canadian
Community Health Survey (CCHS), cycle 1.1 (2000/2001) and provided consent to 
data linkage with administrative databases were linked to the Ontario Health Insur-
ance Program (OHIP) claims database and the Discharge Abstract Database (DAD) 
In-Patient and Day Procedure database. Prevalence of obesity in this adult population 
was documented using the body mass index (BMI) calculated by Statistics Canada for 
adults aged 20–64 years of age. Socio-demographics (e.g. age, gender, education),
medical characteristics (e.g. comorbidities), health related quality of life (Health Utility 
Index 3), self-reported health and one-year physician and hospitalization costs were
described per BMI category (i.e. underweight, normal weight, overweight and obese).
RESULTS: More than 50% of adult participants were either overweight or obese in
2000/2001. When classiﬁ ed by BMI categories, obese individuals were more likely to
be older, males, have more comorbidities, a lower quality of life and higher one-year
medical costs. A Generalized Linear Model (GLM) indicated that age, gender, obese, 
being inactive and smoker increased signiﬁ cantly the total costs. Compared to normal
weight adults, being underweight or obese were also positive predictors of costs. 
Health-related quality of life, income or being overweight had no impact on costs.
CONCLUSIONS: These results suggest that the burden of obesity in Ontario is 
considerable.
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OBJECTIVES: To quantify prevalence of metabolic syndrome in U.S. ethnic groups
and determine ethnic differences in health habits among sufferers. METHODS: Data 
were obtained from the 2008 U.S. National Health and Wellness Survey (NHWS), a
national, patient-reported, Internet-based study of health care attitudes, behaviors, 
health status, and outcomes of adults aged 18. Metabolic syndrome was deﬁ ned as
experiencing at least three of the following: type 2 diabetes, high cholesterol, hyperten-
sion, BMI q 30. Smoking, regular exercise (16 times/month), visiting a physician in
the past six months, and insurance status were assessed. Frequency weights based on 
age, race and gender were used to calculate prevalence estimates. Logistic regression
was used to determined effects of ethnicity on metabolic syndrome and health habits 
among sufferers while adjusting for other demographics. Analyses were limited to
self-identiﬁ ed white (reference group), black, Hispanic and Asian respondents. 
RESULTS: Of the 61,016 respondents, 9.0% (projected 16.7M; 7.8%) experienced 
metabolic syndrome. Prevalence varied across ethnic groups: White  12.8 M, 8.4%; 
Black  19.5 M, 7.9%; Hispanic  1.6 M, 5.8%; Asian  0.3 M, 3.2%). Adjusting 
for other demographics, blacks were more likely (OR  1.35, p  0.01), Asians less
likely (OR  0.58, p  0.01), and Hispanics equally as likely to have metabolic syn-
drome as whites. There were signiﬁ cant (p  0.05) ethnic differences in selected health 
habits among sufferers after adjusting for other demographics. Speciﬁ cally, Hispanics 
were 0.69 times as likely to be current smokers and 0.69 times as likely to visit a 
primary care physician as whites, and blacks were 0.64 times as likely to have health 
insurance as whites. CONCLUSIONS: Complex conditions such as metabolic syn-
drome present new challenges in ethnic health and health care research due to varia-
tions in the prevalence and risk factors by ethnic groups. Among metabolic syndrome
sufferers, ethnic disparities in health habits, physician visits, and insurance status may 
lead to differential outcomes by ethnic group.
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ESTIMATION OF CAUSAL EFFECTS OF PHYSICAL ACTIVITY ON
OBESITY BY A RECURSIVE BIVARIATE PROBIT MODEL
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OBJECTIVES: The study objective was to quantify the causal effect of physical activity
(PA) on obesity controlling for unobservable factors causing bias. METHODS: Data 
from the MEPS’s Household Component (2006), a nationally representative survey of 
the U.S. civilian non-institutionalized population, were used. Analysis accounted for 
the survey’s clusters, strata and sampling weights. Treatment variable was a binary
indicator if an individual spent half hour or more in moderate to vigorous physical
